However, when EphB4 knock out tumors in mice were treated with EphA4 inhibitor, a significant tumor growth reduction was observed (Fig. 6d and Supplementary Fig. 20), suggesting that EphA4 plays a compensatory role to enhance tumor growth in vivo following the loss of cancer cell EphB4. Here, EPHB4 is linked to cancer.